These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 15314722

  • 21. EASL Recommendations on Treatment of Hepatitis C 2018.
    European Association for the Study of the Liver.
    J Hepatol; 2018 Aug; 69(2):461-511. PubMed ID: 29650333
    [No Abstract] [Full Text] [Related]

  • 22. Alcohol and hepatitis C: do we have a drinking problem?
    Everhart JE.
    Gastroenterology; 2006 May; 130(6):1912-4. PubMed ID: 16697753
    [No Abstract] [Full Text] [Related]

  • 23. Peripheral lymphocyte subsets vary with stage of hepatitis C virus-associated liver disease.
    Morita K, Fukuda Y, Nakano I, Katano Y, Hayakawa T.
    Hepatogastroenterology; 2005 May; 52(66):1803-8. PubMed ID: 16334781
    [Abstract] [Full Text] [Related]

  • 24. The clinical picture of acute and chronic hepatitis C.
    Esteban JI, Cordoba J, Sauleda S.
    Curr Stud Hematol Blood Transfus; 1998 May; (62):102-18. PubMed ID: 9507806
    [No Abstract] [Full Text] [Related]

  • 25. Gastrointestinal bleeding, cryoglobulinemia, and hepatitis C.
    Fine GD, Trainer TD, Krawitt EL.
    Am J Gastroenterol; 2004 May; 99(5):964-5. PubMed ID: 15128376
    [No Abstract] [Full Text] [Related]

  • 26. [Guidelines for the sociomedical assessment of performance in patients suffering from chronic obstructive lung diseases (COPD) and bronchial asthma. II: Sociomedical assessment of performance, Annex Part B, bibliography see Part I, Gesundheitswesen 2004, 66: 263f].
    Becker E, Horn S, Hussla B, Irle H, Knorr I, Korsukéwitz C, Pottins I, Rohwetter M, Schuhknecht P, Timner K.
    Gesundheitswesen; 2004 Jul; 66(7):439-56. PubMed ID: 15314736
    [Abstract] [Full Text] [Related]

  • 27. New hepatitis C guidelines for the Asia-Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    Farrell GC.
    J Gastroenterol Hepatol; 2007 May; 22(5):607-10. PubMed ID: 17444844
    [No Abstract] [Full Text] [Related]

  • 28. [Is reaching consensus on the development of guidelines nonsense?].
    Selbmann HK.
    Z Arztl Fortbild Qualitatssich; 2006 May; 100(7):536-41. PubMed ID: 17137068
    [Abstract] [Full Text] [Related]

  • 29. Delta-S entropy variation system: a novel biophysical approach to treat chronic-degenerative processes. The challenge of liver cirrhosis.
    Marineo G, Marotta F.
    Saudi Med J; 2004 Aug; 25(8):979-82. PubMed ID: 15322583
    [No Abstract] [Full Text] [Related]

  • 30. Comment on the updated AASLD practice guidelines for the diagnosis, management, and treatment of hepatitis C: treating active drug users.
    Swan T, Curry J.
    Hepatology; 2009 Jul; 50(1):323-4; author reply 324-5. PubMed ID: 19554546
    [No Abstract] [Full Text] [Related]

  • 31. [Hepatitis C--the forgotten epidemic].
    Meyer R.
    Dtsch Med Wochenschr; 2006 Oct 27; Suppl 1():68. PubMed ID: 17598256
    [No Abstract] [Full Text] [Related]

  • 32. [Care of persons with diabetes in Germany--where do we stand today?].
    Scherbaum WA, Hauner H.
    Dtsch Med Wochenschr; 2003 May 23; 128(21):1159-60. PubMed ID: 12761687
    [No Abstract] [Full Text] [Related]

  • 33. Latin American Association for the Study of the Liver Practice Guidelines. Diagnosis, management, and treatment of hepatitis C.
    Latin American Association for the Study of the Liver.
    Ann Hepatol; 2010 May 23; 9 Suppl():8-26. PubMed ID: 20713990
    [No Abstract] [Full Text] [Related]

  • 34. Hepatitis C and general practice: the challenge continues.
    Kidd M.
    Aust Fam Physician; 2003 Oct 23; 32(10):795. PubMed ID: 14596072
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical practice guidelines: objectivity and standardization].
    Shen N, He B.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 11; 87(34):2377-9. PubMed ID: 18036310
    [No Abstract] [Full Text] [Related]

  • 36. Acute hepatitis C: current status and remaining challenges.
    Santantonio T, Wiegand J, Gerlach JT.
    J Hepatol; 2008 Oct 11; 49(4):625-33. PubMed ID: 18706735
    [Abstract] [Full Text] [Related]

  • 37. Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries.
    Reimer J, Schulte B, Castells X, Schafer I, Polywka S, Hedrich D, Wiessing L, Haasen C, Backmund M, Krausz M.
    Clin Infect Dis; 2005 Apr 15; 40 Suppl 5():S373-8. PubMed ID: 15768351
    [Abstract] [Full Text] [Related]

  • 38. Molecular adsorbents recirculating system treatment in acute-on-chronic hepatitis patients on the transplant waiting list improves model for end-stage liver disease scores.
    Novelli G, Rossi M, Pugliese F, Poli I, Ruberto E, Martelli S, Nudo F, Morabito V, Mennini G, Berloco PB.
    Transplant Proc; 2007 Apr 15; 39(6):1864-7. PubMed ID: 17692635
    [Abstract] [Full Text] [Related]

  • 39. Approach of primary care physicians to hepatitis C: an educational survey from a Southern Italian area.
    Cozzolongo R, Cuppone R, Petruzzi J, Stroffolini T, Manghisi OG.
    J Infect; 2005 Dec 15; 51(5):396-400. PubMed ID: 16321651
    [Abstract] [Full Text] [Related]

  • 40. [Immune status of patients with different outcomes of acute hepatitis C].
    Iushchuk ND, Dudina KR, Znoĭko OO, Mal'kov IG, Kuzina LE, Cheshik DS, Isaguliants MG.
    Ter Arkh; 2005 Dec 15; 77(11):32-7. PubMed ID: 16404859
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.